MARKET

ICUI

ICUI

ICU Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

183.07
-6.78
-3.57%
After Hours: 183.07 0 0.00% 16:09 10/28 EDT
OPEN
187.59
PREV CLOSE
189.85
HIGH
189.94
LOW
182.37
VOLUME
116.89K
TURNOVER
--
52 WEEK HIGH
236.51
52 WEEK LOW
158.01
MARKET CAP
3.83B
P/E (TTM)
47.46
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Does ICU Medical's (NASDAQ:ICUI) CEO Salary Compare Well With Industry Peers?
Simply Wall St. · 10/07 13:51
Hedge Funds Are Betting On ICU Medical, Inc. (ICUI)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend
Insider Monkey · 09/15 03:53
I Ran A Stock Scan For Earnings Growth And ICU Medical (NASDAQ:ICUI) Passed With Ease
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Simply Wall St. · 09/11 14:36
ICU Medical, Inc. to Present at Morgan Stanley 18th Annual Global Healthcare Conference
SAN CLEMENTE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present virtually at the Morgan
GlobeNewswire · 09/08 11:30
ICU Medical stock price target raised to $218 from $199 at KeyBanc Capital
ICUI | Complete ICU Medical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
marketwatch.com · 09/02 09:57
ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly
Simply Wall St. · 08/19 18:15
ICU Medical shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
Benzinga · 08/11 12:58
The Daily Biotech Pulse: Regulatory Setback For Fennec Pharma, Ligand To Buy Pfenex, Inovio Says Phase 2/3 Coronavirus Vaccine Study Starts In September
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)
Benzinga · 08/11 12:20
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ICUI. Analyze the recent business situations of ICU Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ICUI stock price target is 222.67 with a high estimate of 240.00 and a low estimate of 210.00.
EPS
Institutional Holdings
Institutions: 399
Institutional Holdings: 21.64M
% Owned: 103.34%
Shares Outstanding: 20.94M
TypeInstitutionsShares
Increased
93
1.18M
New
86
317.08K
Decreased
94
1.46M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-3.32%
Healthcare Equipment & Supplies
-3.37%
Key Executives
Chairman/Chief Executive Officer/Director
Vivek Jain
Chief Financial Officer/Treasurer
Brian Bonnell
Chief Operating Officer
Christian Voigtlander
Vice President/General Counsel/Secretary
Virginia Sanzone
Vice President/General Manager
Daniel Woolson
Lead Director/Independent Director
David Greenberg
Director
George Lopez
Independent Director
Donald Abbey
Independent Director
Elisha Finney
Independent Director
David Hoffmeister
Independent Director
Robert Swinney
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ICUI
ICU Medical, Inc. is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company's product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. The primary critical care products it manufactures are Hemodynamic Monitoring Systems, SafeSet Closed Blood Sampling and Conservation System, Transpac Consumable Blood Pressure Transducers and Other Critical Care Products. The primary oncology products it manufactures are ChemoLock Needlefree CSTD, ChemoClave Needlefree CSTD and Diana Hazardous Drug Compounding System. As of December 31, 2016, its products were used in acute care hospitals and ambulatory clinics in more than 65 countries throughout the world.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of ICU Medical Inc stock information, including NASDAQ:ICUI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICUI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ICUI stock methods without spending real money on the virtual paper trading platform.